Dr. Cynthia Cai is an executive and investor with over twenty-five years of experience in the healthcare and life science industry. Extensive experience in equity investment, board membership, marketing, and business development. In-depth understanding of global biotech and life science business, widely recognized as having a unique ability to bridge collaboration between scientists and businesses, between the Eastern and Western worlds.
Dr. Cai is the founder and president of Tharton Consulting, which provides investment and management consulting services. She is also a venture partner of Viva BioInnovator, an equity investor in biotech innovation with novel solutions to cross multiple therapeutic areas. Before that, she served as senior advisor to Northern Light Venture Capital, for its healthcare investment effort in the United States. Previously Dr. Cai had progressive leadership roles with Agilent Technologies, as global associate vice president of marketing, she was responsible for its billion-dollar Chromatography, Automation, and Mass Spec. business.
Dr. Cai serves on the board of directors for Spectral MD (London: SMD), Arthrosi Therapeutics, AceLink Therapeutics, Amberstone Biosciences, and Basking Biosciences. She is also a member of the board of the Science History Institute in Philadelphia.
Dr. Cai earned a B.A. and M. Eng. from Tsinghua University in Beijing, received her Ph.D. in Chemistry from the University of Massachusetts, and an MBA from The Wharton Business School of the University of Pennsylvania. She had been a regular speaker at healthcare investment conferences such as BIO International Convention; RESI; China Focus at J.P. Morgan, SAPA Annual Conference, and Wharton China Business Forum. Dr. Cai is also a long-time career advisor for Tsinghua Global MBA and Wharton Executive MBA students.
